Table of Contents
Introduction
Hereditary cancer syndromes are caused by inherited mutations in one or more genes and are characterized by a genetic proneness to particular types of cancer, frequently manifesting early in life. The majority of hereditary cancer disorders are autosomal dominant in character, which means that even if the genes are passed from one parent, they can show clinical manifestations in an individual. Lynch syndrome, Li-Fraumeni syndrome, Cowden syndrome, Peutz-Jeghers syndrome, hereditary diffuse gastric cancer, and hereditary breast and ovarian cancer syndrome are the most prevalent hereditary cancer syndromes. To identify individuals and families who may have a higher risk of acquiring a particular type of cancer, a hereditary cancer risk assessment is essential.
What Is Multiple Primary Cancer?
Multiple primary cancers (MPCs) are also known as multiple primary malignancies. They are defined as two or more separate primary tumors occurring in the same or different organs or tissues in a single patient. Due to the increased number of cancer survivors and the potential side effects of therapies like radiation and chemotherapy, more people are at risk of developing multiple primary malignancies. Tumor detection has become easy due to improved techniques. Long-term health increasingly depends on recognizing and controlling the risks of having numerous primary malignancies, especially as more individuals survive cancer.
What Are the Different Types of Rare Genetic Syndromes Associated with Multiple Primary Cancers?
-
Li-Fraumeni Syndrome -
-
Li-Fraumeni syndrome is an uncommon genetic disorder that primarily affects young adults and children. It raises the chance of brain, adrenal gland, breast, and sarcoma among other malignancies. The TP53 (tumor suppressor gene) gene aids in preventing abnormal cell development. Any mutation in the TP53 gene causes Li-Fraumeni syndrome. It is also known as the sarcoma, breast, leukemia, and adrenal gland [SBLA] cancer syndrome.
-
Radiation exposure increases the likelihood of developing numerous malignancies in individuals with this syndrome. Family members of a person with Li-Fraumeni syndrome, especially children, may also carry the mutated gene. To lower the risk, families may want to consider testing or early cancer screening. Since radiation therapy carries a higher risk for these patients, doctors may decide not to use it. To reduce the risk of acquiring cancer, the emphasis lies on implementing preventative measures.
-
-
Lynch Syndrome -
-
Lynch syndrome is an inherited disorder that increases the chance of colon cancer. It is sometimes referred to as hereditary non-polyposis colorectal cancer (HNPCC). The risk of colorectal cancer is higher in those with this syndrome, usually occurring before the age of fifty. In addition to colon cancer, Lynch syndrome raises the risk of developing cancers in the brain, skin, breast, prostate, ureters (tubes that deliver urine), bile duct, endometrial (uterine lining), ovarian, stomach, small intestine, pancreas, kidney, and brain.
-
Mutations in mismatch repair (MMR) genes, including MLH1, MSH2, MSH6, PMS2, and EPCAM, are the cause of the condition. Usually, these genes aid in repairing damaged DNA (deoxyribonucleic acid). DNA errors that occur in cells due to the malfunctioning of one of these genes may result in additional gene mutations and, ultimately, cancer. Using precise criteria such as the Amsterdam criteria and revised Bethesda guidelines, doctors evaluate a patient's personal and family cancer history to determine the possibility of Lynch syndrome. The mutations in the genes linked to Lynch syndrome can then be found through genetic testing.
-
Microsatellite instability (MSI) in cancer cells can be tested for in patients with Lynch syndrome-associated malignancies. If MSI is present, it may be a sign of Lynch syndrome since it indicates abnormal MMR gene function. Close relatives of an individual with Lynch syndrome have a 50 percent probability of carrying the same mutation. For certain relatives, testing or early cancer screening may be advised in addition to cancer prevention measures.
-
-
Hereditary Breast and Ovarian Cancer Syndrome (HBOC) -
-
Families with individuals who get breast or ovarian cancer, frequently at an earlier age than usual, are said to have Hereditary Breast and Ovarian Cancer Syndrome (HBOC). Some people may experience multiple malignancies, such as ovarian and breast cancer or cancer in both breasts. A hereditary mutation in either the BRCA1 (breast cancer type 1) or BRCA2 (breast cancer type 2) gene is the primary cause of HBOC in many cases. On the other hand, not all families with a history of these cancers have these gene mutations.
-
It is thought by scientists that there may be additional genes that are still unidentified that cause HBOC. In addition, this syndrome may result in various malignancies such as prostate, pancreatic, male breast, fallopian tube, and primary peritoneal cancers. Some people may have more than one kind of cancer; for example, women may have both breast and ovarian cancer, while males may have both pancreatic and prostate cancer. Breast cancer is uncommon in men.
-
Hence, genetic counseling and BRCA mutation testing are frequently provided to men who develop the disease. Genetic counseling is also provided to the females. Given that there is a 50 percent possibility that close relatives would inherit the mutation, testing and preventative health measures should be considered. The risk of ovarian and breast cancer may also be increased due to the presence of other genetic cancer syndromes and not only HBOC.
-
-
Cowden Syndrome - An uncommon genetic disorder called Cowden syndrome is brought on by abnormalities in the PTEN (phosphatase and tensin) gene. Since it is autosomal dominant, it can be caused by one copy of the gene from either parent. Macrocephaly, or a larger head, is a characteristic feature of Cowden syndrome. By 30, most people have papillomatous papules on their faces and mucosal membranes. The risk of breast cancer, endometrial cancer, colon cancer, and thyroid cancer is markedly increased by Cowden syndrome.
-
Hereditary Diffuse Gastric Cancer - The cause of hereditary diffuse gastric cancer is pathogenic variations of the CDH1 (cadherin) gene, which is associated with an elevated risk of colorectal, lobular breast, and diffuse gastric cancer.
-
Peutz-Jeghers Syndrome - Pathogenic mutations in the serine/threonine kinase 11 (STK11) gene cause Peutz-Jeghers syndrome. The malignancies associated with this syndrome include breast cancer, uterine cancer, cervical cancer, ovarian sex cord-stromal cancer, gastric cancer, and colon cancer.
What Is the Importance of Genetic Testing and Counseling?
Individuals who have a significant family history of cancer might be interested in finding out more about their genetic makeup. This could assist the individual or additional family members in making future healthcare plans. Genetic testing on blood or saliva (spit) samples can frequently identify inherited mutations since they impact every cell in an individual's body. Nevertheless, not everyone benefits from genetic testing, so it is crucial first to consult a genetic counselor to determine whether testing is a good fit or not.
Conclusion
Physicians can screen for familial cancer syndromes, recommend suitable patients for genetic testing and counseling, and discuss life-saving cancer risk reduction strategies. Multigene panel testing can be used to find asymptomatic and at-risk individuals. These people should then be transferred to the right experts or institutes for monitoring, routine follow-up, and, if necessary, preventive surgery.
